Safe and effective sedation in endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a randomized comparsion between propofol and midazolam.
Not Applicable
- Conditions
- superficial esophageal squamous cell carcinoma
- Registration Number
- JPRN-UMIN000013601
- Lead Sponsor
- Department of Gastroenterology, Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 132
Inclusion Criteria
Not provided
Exclusion Criteria
Severe disease in heart, lung, liver, or kidney. Allergic episode with propofol or midazolam. Women in pregnancy or breast-feeding Any other reasosn by which docter judged inappropriate case.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method therapeutic interruption rate
- Secondary Outcome Measures
Name Time Method therapeutic achievement rate treatment time adverse event risk factors for a poor response to sedation recovery time satisfaction